News & Updates
Filter by Specialty:
Trabectedin fails to improve survival outcomes in recurrent ovarian, primary peritoneal, or fallopian tube cancer
Trabectedin did not improve overall survival (OS) or progression-free survival (PFS) compared with chemotherapy in women with recurrent ovarian, primary peritoneal, or fallopian tube cancer and BRCA mutation or BRCAness phenotypes, according to results of the phase III MITO23 trial.
Trabectedin fails to improve survival outcomes in recurrent ovarian, primary peritoneal, or fallopian tube cancer
07 Sep 2022Levonorgestrel-releasing intrauterine system reduces pelvic pain but may increase expulsion risk
In the treatment of patients with organic disease and heavy menstrual bleeding and/or dysmenorrhea, the use of levonorgestrel-releasing intrauterine system (LNG-IUS) attenuates chronic pelvic pain, according to a study. However, it appears to confer an increased risk of expulsion for some women.
Levonorgestrel-releasing intrauterine system reduces pelvic pain but may increase expulsion risk
06 Sep 2022Tension-free vaginal tape for stress incontinence safe, effective in long term
Among women with stress urinary incontinence, the retropubic tension-free vaginal tape (TVT) retains its efficacy up to 24 years after initial placement, with adverse effects being uncommon and having a low impact on quality of life, according to a study.
Tension-free vaginal tape for stress incontinence safe, effective in long term
05 Sep 2022Hypertensive disorders of pregnancy: A risk factor for dementia?
Individuals with a history of hypertensive disorders of pregnancy (HDP) appear to have an increased risk of developing dementia, particularly vascular dementia, according to a study presented at AAIC 2022.